Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$999,994
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cherry Brian N +$1000K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-08-15 MCGRATH JOHN EVP & Chief Financial Officer Option exercise · Restricted Stock Units −7,697 12,829
2017-08-15 Haqq Christopher EVP, R&D & Chief Scientific Of Option exercise +829 362,909
2017-08-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −7,604 $14.75 $112K 355,305
2017-08-15 Haqq Christopher EVP, R&D & Chief Scientific Of Option exercise · Restricted Stock Units −829 1,382
2017-08-15 Clark Mitchall G. EVP & Chief R & QA Officer Option exercise +7,211 162,151
2017-08-15 Clark Mitchall G. EVP & Chief R & QA Officer Option exercise · Restricted Stock Unites −7,211 19,231
2017-08-15 Ciechanover Isaac E. Chief Executive Officer Option exercise +5,908 737,767
2017-08-15 Ciechanover Isaac E. Chief Executive Officer Option exercise · Restricted Stock Units −5,908 9,846
2017-08-11 Ciechanover Isaac E. Chief Executive Officer Sale −2,200 $14.58 $32K 446,178
2017-08-10 Ciechanover Isaac E. Chief Executive Officer Sale −2,200 $14.75 $32K 448,378
2017-07-25 Ciechanover Isaac E. Chief Executive Officer Sale −2,500 $15.97 $40K 450,778
2017-07-25 Ciechanover Isaac E. Chief Executive Officer Sale −200 $16.79 $3K 450,578
2017-07-24 Ciechanover Isaac E. Chief Executive Officer Sale −2,500 $16.89 $42K 453,578
2017-07-24 Ciechanover Isaac E. Chief Executive Officer Sale −300 $17.32 $5K 453,278
2017-07-17 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −6,000 $14.92 $90K 362,080
2017-06-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −6,000 $12.65 $76K 368,080
2017-06-09 Gallagher Carol Giltner Director Sale −1,000 $13.15 $13K 107,374
2017-06-08 SEIDENBERG BETH C Director Grant or award +5,000 13,689
2017-06-08 SEIDENBERG BETH C Director Grant or award · NonQualified Stock Option (Right to Buy) +21,500 21,500
2017-06-08 Gallagher Carol Giltner Director Grant or award +5,000 108,374

Page 42 of 44 · 867 trades